GlassScriptPhysician profile
Julio R Olaya
NPI 1285724757
$22,059.57
in general payments reported to CMS, 2019-2025
26 companies · $7,171 in 2025
The $7,171 reported for 2025 was more than what 94% of Pain Medicine providers received nationally (typical 2025 total: $515).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,379 · 2020: $6,662 · 2021: $2,666 · 2022: $797 · 2023: $97.42 · 2024: $287 · 2025: $7,171.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,473 · Food and Beverage: $2,029 · Consulting Fee: $1,053.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,473.39 |
| Food and Beverage | $2,029.28 |
| Consulting Fee | $1,053.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $8,194.22 | 2019-2025 | Wavewriter Alpha Prime 16, General - Pain Management, Na |
| Spinefrontier, INC. | $3,218.72 | 2019-2025 | Inspan, Facetfuse, Sijfuse |
| Spinal Simplicity, LLC | $2,522.50 | 2021-2022 | |
| Stryker Corporation | $1,705.86 | 2023-2025 | Mild Device Kit, Spinejack |
| Nevro Corp. | $1,641.91 | 2019-2024 | Senza |
| Nalu Medical, INC. | $1,432.60 | 2021-2025 | Nalu Neurostimulation System |
| Globus Medical, INC. | $1,308.62 | 2025 | Senza |
| Southern Spine, LLC | $1,053.21 | 2025 | |
| Vertiflex, INC. | $234.60 | 2019 | |
| Daiichi Sankyo INC. | $150.25 | 2019 | |
| Mdd US Operations, LLC | $127.77 | 2019 | |
| Horizon Therapeutics Plc | $90.25 | 2019-2022 | |
| Collegium Pharmaceutical, INC. | $53.19 | 2021-2025 | Xtampza |
| Pfizer INC. | $52.44 | 2019-2021 | |
| Vertos Medical, INC. | $38.25 | 2019 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $35.51 | 2020 | |
| Lilly USA, LLC | $25.16 | 2020-2021 | |
| Stimwave Technologies Incorporated | $24.13 | 2022 | |
| Protega Pharmaceutials INC | $24.02 | 2025 | Roxybond |
| Vertex Pharmaceuticals Incorporated | $21.73 | 2025 | |
| Pacira Therapeutics, INC. | $20.74 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $19.09 | 2019 | |
| Kaleo, INC. | $17.55 | 2019 | |
| Bioventus LLC | $16.78 | 2022 | |
| Vgi Medical, LLC | $15.60 | 2022 | |
| Abbvie INC. | $14.87 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julio Olaya listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.